Pfizer Operating Income 2010-2024 | PFE

Pfizer operating income for the twelve months ending June 30, 2024 was $-3.411B, a 115.46% decline year-over-year.

  • Pfizer annual operating income for 2023 was $0.222B, a 99.36% decline from 2022.
  • Pfizer annual operating income for 2022 was $34.944B, a 79.82% increase from 2021.
  • Pfizer annual operating income for 2021 was $19.433B, a 135.55% increase from 2020.

Pfizer Operating Income 2010-2024 | PFE

  • Pfizer annual operating income for 2023 was $0.222B, a 99.36% decline from 2022.
  • Pfizer annual operating income for 2022 was $34.944B, a 79.82% increase from 2021.
  • Pfizer annual operating income for 2021 was $19.433B, a 135.55% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B